Annals of Nuclear Medicine

Papers
(The TQCC of Annals of Nuclear Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Deep learning study on the mechanism of edge artifacts in point spread function reconstruction for numerical brain images96
PD1 blockade alters cell-cycle distribution and affects 3′-deoxy-3′-[18F]fluorothymidine uptake in a mouse CT26 tumor model64
Usefulness of albumin–globulin ratio as a clinical prognostic factor in patients with thyroid cancer treated with radioiodine41
First validation of stress myocardial perfusion scintigraphy using a novel reconstruction process39
Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms36
Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC30
Response to the letter to the editor28
Brain PET motion correction using 3D face-shape model: the first clinical study27
Temporal metabolic response and mRNA COVID-19 vaccination27
Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images25
Direct comparison of F-18 FDG PET/CT and MRI to predict pathologic response to neoadjuvant treatment in locally advanced rectal cancer: a meta-analysis23
Conversion from dose length product to effective dose for the CT component of whole-body PET/CT23
Abnormal [18F]fluorodeoxyglucose accumulation to tori tubarius in IgG4-related disease22
A first-in-man study of [18F] FEDAC: a novel PET tracer for the 18-kDa translocator protein22
Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands21
A novel objective method for discriminating pathological and physiological colorectal uptake in the lower abdominal region using whole-body dynamic 18F-FDG-PET18
Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy18
Acquisition count dependence of the specific binding ratio in 123I-FP-CIT SPECT18
[18F]-FDG uptake in brain slices prepared from an aged mouse model of Alzheimer’s disease using a dynamic autoradiography technique16
Optimization of injection dose in 18F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan15
Booster administration of Tc-99m PMT for delayed static imaging in patients with biliary atresia15
Consistency and prognostic value of preoperative staging and postoperative pathological staging using 18F-FDG PET/MRI in patients with non-small cell lung cancer14
New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map14
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis14
PET-guided attention for prediction of microvascular invasion in preoperative hepatocellular carcinoma on PET/CT13
18F-FDG PET/CT for monitoring anti-PD-1 therapy in patients with non-small cell lung cancer using SUV harmonization of results obtained with various types of PET/CT scanners used at different centers13
Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden13
Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted ther12
Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer12
Voxel-based analysis of age and gender effects on striatal [123I] FP-CIT binding in healthy Japanese adults12
Assessing dedicated breast PET performance in breast cancer screening alongside digital mammography, digital breast tomosynthesis, and ultrasound: a reader's insight12
Response to the letter to the editor12
Characteristics of surgically transposed ovaries on 18F-FDG PET/CT among patients with cancer11
Manual on the proper use of meta-[211At] astato-benzylguanidine ([211At] MABG) injections in clinical trials for targeted alpha therapy (1st edition)11
[68Ga]Ga-NODAGAZOL uptake in atherosclerotic plaques correlates with the cardiovascular risk profile of patients11
I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response11
99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients11
Effectiveness of shielding materials against 177Lu gamma rays and the corresponding distance relationship11
Transient ischemic dilatation with adenosine 99mTc-sestamibi stress: prognostic significance in patients with normal myocardial perfusion11
Optimal relaxation parameters of dynamic row-action maximum likelihood algorithm and post-smoothing filter for image reconstruction of dedicated breast PET10
Imaging of cardiac amyloidosis using dynamic 18F-FPYBF-2 positron emission tomography10
Focal severe decrease in myocardial technetium-99 m sestamibi uptake indicates ventricular irreversibility in patients with dilated cardiomyopathy10
Correlations between whole body volumetric parameters of 68Ga-PSMA PET/CT and biochemical-histopathological parameters in castration-naive and resistant prostate cancer patients10
Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials10
13N-ammonia positron emission tomography-derived left-ventricular strain in patients after heart transplantation validated using cardiovascular magnetic resonance feature tracking as reference10
Role of visual information in multimodal large language model performance: an evaluation using the Japanese nuclear medicine board examination9
18F-FES and 18F-FDG PET/CT imaging as a predictive biomarkers for metastatic breast cancer patients undergoing cyclin-dependent 4/6 kinase inhibitors with endocrine treatment9
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-2239
Development of a novel small-animal myocardial phantom can evaluate the image quality of dual-isotope simultaneous acquisition (DISA)9
Dosimetry and efficacy of a tau PET tracer [18F]MK-6240 in Japanese healthy elderly and patients with Alzheimer’s disease9
Coronary plaque instability assessed by positron emission tomography and optical coherence tomography9
The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphoma9
Comparison of early and standard 18F-PSMA-11 PET/CT imaging in treatment-naïve patients with prostate cancer9
Predictive factors of tumor sink effect: Insights from 177Lu-Prostate-specific membrane antigen therapy9
Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects9
Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions9
Validation of advanced hybrid SPECT/CT system using dynamic anthropomorphic cardiac phantom8
Next day sentinel node biopsy for melanoma after lymphoscintigraphy using 99mTc-labelled nanocolloid does not adversely affect long-term outcomes8
Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients8
Feasibility of position emission tomography derived endocardial wall strain: direct comparison with magnetic resonance using hybrid 13N ammonia PETMR system8
Role of volumetric parameters obtained from 68 Ga-PSMA PET/CT and 18F-FDG PET/CT in predicting overall survival in patients with mCRPC receiving taxane therapy8
The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer8
Assessment of post-pyeloplasty renal drainage in antenatally detected hydronephrosis by 99mTc-L, L-Ethylenedicysteine renal scintigraphy: the importance of delayed imaging8
Correction to: Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study8
Voxel-based dosimetry with integrated Y-90 PET/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheres8
Physiological biodistribution on Ga68-PSMA PET/CT and the factors effecting biodistribution8
68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT8
Novel prediction model combining PET/CT metabolic parameters, inflammation markers, and TNM stage: prospects for personalizing prognosis in nasopharyngeal carcinoma8
Correction: Novel indices representing heterogeneous distributions of myocardial perfusion imaging8
Evaluation of two-dimensional total bone uptake (2D-TBU) and bone scan index (BSI) extracted from active bone metastatic burden on the bone scintigraphy in patients with radium-223 treatment7
Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up7
A different overview of staging PET/CT images in patients with esophageal cancer: the role of textural analysis with machine learning methods7
Shine-through artifact due to high-radioactivity bladder and bowel gas in 18F-FDG PET/CT: impact of time-of-flight algorithm and radioactivity concentration of urine in the bladder on the occurrence o7
Diagnostic performance of F-18 FDG PET/CT in differentiating autoimmune pancreatitis from pancreatic cancer: a systemic review and meta-analysis7
Linking cardiac and extracardiac sarcoidosis and their clinical outcome: 18F-FDG PET/CT analysis in patients with systemic cardiac sarcoidosis7
Serial change in perfusion–metabolism mismatch after coronary artery bypass grafting7
Diagnostic value of [18F]Fluorocholine PET/CT in detection of primary medullary thyroid cancer7
Associations of frontal QRS-T angle with left ventricular volume and function derived from ECG-gated SPECT in patients with advanced chronic kidney disease7
An evaluation of the response to neoadjuvant chemotherapy for osteosarcoma of extremities: PERCIST versus RECIST 1.1 criteria after long-term follow-up7
Diagnostic performance of a deep-learning model using 18F-FDG PET/CT for evaluating recurrence after radiation therapy in patients with lung cancer7
Inferences of SPECT renal dynamic imaging injection quality based on lung and abdominal aorta imaging features7
Preoperative prediction of regional lymph node metastasis of colorectal cancer based on 18F-FDG PET/CT and machine learning7
Validity of the γ-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test7
Assessment of regional and total skeletal metabolism using 18F-NaF PET/CT in patients with chronic kidney disease7
From FDG and beyond: the evolving potential of nuclear medicine6
Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose–positron emission tomography to differentiate between benign and malignant lesions6
Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer6
Beads phantom for evaluating heterogeneity of SUV on 18F-FDG PET images6
Impact of patient body habitus on image quality and quantitative value in bone SPECT/CT6
Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients6
Convolutional neural network-based program to predict lymph node metastasis of non-small cell lung cancer using 18F-FDG PET6
Cardiac sympathetic activity and relationship to cardiac events and left ventricular reverse remodeling in patients with non-ischemic dilated cardiomyopathy6
The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer6
Radiotherapy planning of lymphomas: role of metabolic imaging with PET/CT6
Comparative evaluation of radionuclide therapy using 90Y and 177Lu6
Quantitative assessment of 99mTc-methylene diphosphonate bone SPECT/CT for assessing bone metastatic burden and its prognostic value in patients with castration-resistant prostate cancers: initial res6
Crossed cerebellar diaschisis: risk factors and prognostic value in focal cortical dysplasia by 18F-FDG PET/CT6
Thyroid function after diagnostic 123I-metaiodobenzylguanidine in children with neuroblastic tumors6
Manual on the proper use of sodium astatide ([211At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition)6
Measuring myocardial blood flow with 82rubidium using Gjedde–Patlak–Rutland graphical analysis6
Usefulness of preset count acquisition in pediatric 99m Tc-DMSA planar imaging6
Comparing laboratory toxicity of selective intra-arterial radionuclide therapy for primary and metastatic liver tumors: resin versus glass microspheres6
Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis6
Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive,6
Inverse correlation between age of onset and myocardial amyloid deposition quantified by 99mTc-PYP scintigraphy in patients with wild-type transthyretin amyloid cardiomyopathy5
F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 tria5
18F-FDG PET/CT biomarkers as predictors of long term outcomes and survival rates in patients with high risk malignant pulmonary masses/nodules treated with stereotactic ablative radiotherapy5
Comparison of 68Ga-DOTANOC PET/CT with cardiac MRI in patients with clinical suspicion of cardiac sarcoidosis5
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma5
Clinical value of 18F-FDG PET/CT in IgG4-related disease5
Brown tumors in nuclear medicine: a systematic review5
Impact of [11C]methionine PET with Bayesian penalized likelihood reconstruction on glioma grades based on new WHO 2021 classification5
Correlation between noise pareidolia test scores for visual hallucinations and regional cerebral blood flow in dementia with Lewy bodies5
Manual on the proper use of the 211At-labeled PSMA ligand ([211At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition)5
[18F]FDG PET/CT is useful in discriminating invasive adenocarcinomas among pure ground-glass nodules: comparison with CT findings—a bicenter retrospective study5
18F-FLT PET/CT imaging for early monitoring response to CDK4/6 inhibitor therapy in triple negative breast cancer5
Visualization of small brain nuclei with a high-spatial resolution, clinically available whole-body PET scanner5
The relationship between global cardiac and regional left atrial sympathetic innervation and epicardial fat in patients with atrial fibrillation5
Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review5
Myocardial perfusion quantification with Rb-82 PET: good interobserver agreement of Carimas software on global, regional, and segmental levels5
High detection rate in [18F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients5
The feasibility of ultralow-activity 18F-FDG dynamic PET imaging in lung adenocarcinoma patients through total-body PET/CT scanner5
0.20186495780945